Molecular Mechanisms of Steroid-Induced Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$69,334
Active Dates
April 01, 2004 - September 30, 2006
Grant ID
G2004018
Summary
Steroid medications are widely used to treat many inflammatory conditions. However, there can be undesirable side effects of steroid use, especially when they are used long-term. One of the side effects in the eye is the development of increased eye pressure, which can lead to glaucoma and, ultimately, vision loss. Approximately one out of every three normal people is at risk of developing steroid-induced glaucoma. Using donor eyes, Dr. Kwon and his team are comparing the differences between people who develop steroid-induced glaucoma and those who do not. It is already known that steroids influence which genes are turned on and off in the body’s cells, including the drainage area of the eye called the trabecular meshwork. Dr. Kwon’s research will help scientists understand why the pressure in the eye is maintained at a constant level in some people, and what goes wrong in the eyes of those who react to steroids with an elevation of eye pressure. It is hoped that this information will be helpful in finding treatments that avoid steroid-induced glaucoma, allowing the safer use of steroids in patients with ocular inflammation.
Related Grants
National Glaucoma Research
How the Microenvironment Affects Schlemm’s Canal Cell Behavior
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Samuel Herberg, PhD
Current Organization
SUNY Upstate Medical University
How the Microenvironment Affects Schlemm’s Canal Cell Behavior
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Samuel Herberg, PhD
Current Organization
SUNY Upstate Medical University
National Glaucoma Research
The Impact of Glaucoma on Light-Mediated Mood and Sleep Disorders
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Xiaorong Liu, PhD
Current Organization
University of Virginia
The Impact of Glaucoma on Light-Mediated Mood and Sleep Disorders
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Xiaorong Liu, PhD
Current Organization
University of Virginia
National Glaucoma Research
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
Current Organization
Oregon Health & Science University
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Diana C. Lozano, PhD
Current Organization
Oregon Health & Science University